SCHEMBL12691848

SCHEMBL12691848

O=C1c2ccccc2C(=O)c2c(O)c(O)cc(OCCCCOc3cc(O)c(O)c4c3C(=O)c3ccccc3C4=O)c21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.60
▸ KMT2A Q03164 6/20 0.60
▸ MAPT P10636 5/20 0.60
▸ MAOA P21397 4/20 0.60
▸ KDM4E B2RXH2 3/20 0.60
▸ ALDH1A1 P00352 3/20 0.60
▸ HPGD P15428 3/20 0.60
▸ TDP1 Q9NUW8 3/20 0.60
▸ CYP3A4 P08684 2/20 0.60
▸ ALOX15 P16050 2/20 0.60
▸ ALOX12 P18054 2/20 0.60
▸ MAPK1 P28482 2/20 0.60
▸ RECQL P46063 2/20 0.60
▸ DAPK1 P53355 2/20 0.60
▸ CYP1B1 Q16678 2/20 0.60
▸ HSD17B10 Q99714 2/20 0.60
▸ BRCA1 P38398 2/20 0.60
▸ TTR P02766 1/20 0.60
▸ CYP1A1 P04798 1/20 0.60
▸ HSPD1 P10809 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12581682 0.98 MEN1 (0.58) MEN1KMT2AMAPTMAOAKDM4E
SCHEMBL12581772 0.98 MEN1 (0.58) MEN1KMT2AMAPTMAOAKDM4E
SCHEMBL19821204 0.93 MEN1 (0.53) MEN1KMT2AMAPTMAOAKDM4E
SCHEMBL12582017 0.93 MEN1 (0.53) MEN1KMT2AMAPTMAOAKDM4E
SCHEMBL12581580 0.93 MAPT (0.53) MEN1KMT2AMAPTMAOAKDM4E
SCHEMBL12691899 0.93 MEN1 (0.55) MEN1KMT2AMAPTMAOAKDM4E
SCHEMBL19821200 0.92 MEN1 (0.51) MEN1KMT2AMAPTMAOAKDM4E
SCHEMBL19821201 0.92 MEN1 (0.51) MEN1KMT2AMAPTMAOAKDM4E
SCHEMBL19821202 0.92 MEN1 (0.51) MEN1KMT2AMAPTMAOAKDM4E
SCHEMBL12691737 0.92 MEN1 (0.51) MEN1KMT2AMAPTMAOAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200310267-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2020-10-01 — — US disclosed
US-20200117105-A1 IMAGE FORMING APPARATUS AND PROCESS CARTRIDGE FUJI XEROX CO., LTD. (JP) 2020-04-16 — — US disclosed
US-20200096886-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2020-03-26 — — US disclosed
US-10036969-B2 Electrophotographic photoreceptor, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2018-07-31 — — US disclosed
US-10036969-B2 Electrophotographic photoreceptor, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2018-07-31 — — US disclosed
US-9939743-B2 Electrophotographic photoreceptor, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2018-04-10 — — US disclosed
US-9939743-B2 Electrophotographic photoreceptor, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2018-04-10 — — US disclosed
US-20180067408-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2018-03-08 — — US disclosed
US-20180067408-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2018-03-08 — — US disclosed
US-20180031984-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2018-02-01 — — US disclosed
US-8673524-B2 Electrophotographic photoreceptor, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2014-03-18 — — US disclosed
US-8673524-B2 Electrophotographic photoreceptor, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2014-03-18 — — US disclosed
US-20140045110-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2014-02-13 — — US disclosed
US-20140045110-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2014-02-13 — — US disclosed
US-20130252149-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2013-09-26 — — US disclosed
US-20130252149-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2013-09-26 — — US disclosed
US-20130252147-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2013-09-26 — — US disclosed
US-20130252147-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2013-09-26 — — US disclosed
US-20120244462-A1 METHOD FOR PREPARING ALIZARIN DERIVATIVE COMPOUND, NOVEL ALIZARIN DERIVATIVE COMPOUND, SURFACE MODIFICATION METHOD, PHOTOELECTRIC CONVERSION FILM, PHOTOELECTRIC CONVERSION ELEMENT, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR FUJIFILM CORPORATION (JP) 2012-09-27 — — US disclosed
US-20120244462-A1 METHOD FOR PREPARING ALIZARIN DERIVATIVE COMPOUND, NOVEL ALIZARIN DERIVATIVE COMPOUND, SURFACE MODIFICATION METHOD, PHOTOELECTRIC CONVERSION FILM, PHOTOELECTRIC CONVERSION ELEMENT, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR FUJIFILM CORPORATION (JP) 2012-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120244462-A1 METHOD FOR PREPARING ALIZARIN DERIVATIVE COMPOUND, NOVEL ALIZARIN DERIVATIVE COMPOUND, SURFACE MODIFICATION METHOD, PHOTOELECTRIC CONVERSION FILM, PHOTOELECTRIC CONVERSION ELEMENT, AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR NR2E3, INA, NHERF1 MEN1 3843/4885KMT2A 606/4885MAPT 4813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback